TNF Pharmaceuticals Inc.
13F holders, Q3 2024 (September 30)20holders −3
2new positions
6sold out
$1.62avg. 13F price*
At the end of Q3 2024, 20 institutions reported holding TNF Pharmaceuticals Inc. in their 13F filings, down 3 from Q2 2024. 2 opened new positions and 6 sold out. The largest holders were Geode Capital Management, LLC ($26K), Vanguard Group Inc. ($23K) and BlackRock, Inc. ($6K).
- Company
- TNF Pharmaceuticals Inc.
- CUSIP
- 62856X201
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $219 |
| Exits | 6 | $51K |
All 13F filers, Q2 2024 → Q3 2024: 2,927 shares bought and 27,748 shares sold, net −24,821 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Geode Capital Management, LLC | 0.00% | Add +10.8% | 15,969 | $26K |
| Vanguard Group Inc. | 0.00% | No change | 13,999 | $23K |
| BlackRock, Inc. | 0.00% | — | 3,803 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +3069.2% | 1,236 | $2K |
| Parallel Advisors, LLC | 0.00% | No change | 838 | $1K |
| Group One Trading LLC | 0.00% | No change | 387 | $627 |
| Morgan Stanley | 0.00% | Add +17.6% | 227 | $368 |
| Wells Fargo & Company | 0.00% | No change | 167 | $271 |
| Wilmington Savings Fund Society, FSB | 0.00% | New | 134 | $217 |
| Sandy Spring Bank | 0.00% | No change | 116 | $188 |
| Osaic Holdings, Inc. | 0.00% | Reduce -62.8% | 99 | $159 |
| Harbor Investment Advisory, LLC | 0.00% | No change | 90 | $146 |
| Arvest Investments, Inc. | 0.00% | No change | 34 | $55 |
| NFSG Corp | 0.00% | No change | 34 | $55 |
| Ascentis Wealth Management, LLC | 0.00% | — | 34 | $55 |
| Bank of America Corp. | 0.00% | Add +12.5% | 18 | $30 |
| St. Johns Investment Management Company, LLC | 0.00% | No change | 18 | $29 |
| Sound Income Strategies, LLC | 0.00% | New | 1 | $2 |
| Cornerstone Planning Group LLC | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | No change | 40 | $0 |
"% of holder's portfolio" is TNF PHARMACEUTICALS INC's weight in each manager's 13F, not the share of TNF Pharmaceuticals Inc. the manager owns.